We are pleased to invite investors and analysts to participate in our virtual event on Friday, 13 September 2024, highlighting Roche data presented at the European Association for the Study of Diabetes 2024 Meeting, from 9 - 13 September 2024.   16:00 – 17:30 CEST / 15:00 - 16:30 BST 10:00 – 11:30 am EDT / 7:00 – 8:30 am PDT   The webinar will start with a presentation, followed by a Q&A session (live access to the speakers). The slides will be available for download at 15:00 CEST on the day of the event. > click here   Agenda Welcome Bruno Eschli, Head of Investor Relations Obesity and Diabetes assets in the Cardiovascular Renal and Metabolism pipeline Manu Chakravarthy, SVP and Global Head of Cardiovascular, Renal and Metabolism (CVRM) Product Development CT-388 and CT-996 data presented at EASD Manu Chakravarthy, SVP and Global Head of Cardiovascular, Renal and Metabolism (CVRM) Product Development Q&A   Access to virtual event (pre-registration required) Please pre-register for our webinar here*.   Should you be unable to register for the webinar due to your company IT policy, please send an e-mail to investor.relations@roche.com.   A replay of the webcast will be available via > ir.roche.com   *privacy notice   Best regards,
Bruno Eschli Head of Investor Relations

Roche Investor Relations
Dr. Bruno Eschli Phone: +41 61 68-75284 e-mail: bruno.eschli@roche.com	Dr. Sabine Borngräber Phone: +41 61 68-88027 e-mail: sabine.borngraeber@roche.com
Dr. Birgit Masjost Phone: +41 61 68-84814 e-mail: birgit.masjost@roche.com
Investor Relations North America
Loren Kalm Phone: +1 650 225 3217 e-mail: kalm.loren@gene.com

get the latest news and updates to your inbox.